CanCertainty, profile picture

CanCertainty

Sort by
Surrogate Endpoints: Are drug review processes flexible enough to expedite patient access to new cancer medicines?
QALYs: What are they and how do they impact patient access to new cancer medicines?
Funding Algorithms
pCPA and provincial listings